• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 3. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 4. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,5-disubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,5-disubstituted thiazoles

N-Methyl-1-(5-methyl-1,3-thiazol-2-yl)methanaminedihydrochloride: A Comprehensive Overview

N-Methyl-1-(5-methyl-1,3-thiazol-2-yl)methanaminedihydrochloride, also known by its CAS number 1332531-56-2, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of thiazole derivatives, which have been extensively studied due to their diverse biological activities and potential applications in drug development. The structure of this compound is characterized by a thiazole ring system substituted with a methyl group and a methanamine moiety, which contributes to its unique chemical properties.

The synthesis of N-Methyl-1-(5-methyl-1,3-thiazol-2-yl)methanaminedihydrochloride involves a series of well-established organic reactions, including nucleophilic substitution and acid-base neutralization. The thiazole ring is typically formed through the cyclization of an appropriate thioamide or thiourea derivative under specific reaction conditions. The methylation step introduces the methyl group at the nitrogen atom, enhancing the compound's stability and bioavailability. The dihydrochloride salt form is often preferred for its superior solubility in aqueous media, making it more suitable for pharmaceutical applications.

Recent studies have highlighted the potential of N-Methyl-1-(5-methyl-1,3-thiazol-2-yl)methanaminedihydrochloride as a promising candidate in the development of novel therapeutic agents. Researchers have explored its activity against various enzymes and receptors, demonstrating its potential as a modulator in cellular signaling pathways. For instance, investigations into its interaction with G-protein coupled receptors (GPCRs) have revealed intriguing results, suggesting its role in modulating neurotransmitter systems. These findings underscore the importance of further research into its pharmacokinetic and pharmacodynamic properties.

In addition to its pharmacological applications, CAS 1332531-56-2 has also been studied for its potential in materials science. The thiazole moiety is known to exhibit interesting electronic properties, making it a candidate for use in organic electronics and optoelectronic devices. Recent advancements in thin-film transistor technology have leveraged the unique electronic characteristics of thiazole derivatives, including this compound, to enhance device performance and efficiency.

The safety profile of N-Methyl-1-(5-methyl-1,3-thiazol-2-yl)methanaminedihydrochloride has been evaluated through acute and chronic toxicity studies. These studies indicate that the compound exhibits low toxicity at therapeutic doses, with minimal adverse effects observed in preclinical models. However, further long-term studies are required to fully understand its safety profile and ensure its suitability for human use.

In conclusion, N-Methyl-1-(5-methyl-1,3-thiazol-2-yli)methanaminedihydrochloride (CAS 1332531

• 921145-14-4(N-Methyl-1-(5-methyl-1,3-thiazol-2-yl)methanamine dihydrochloride)
• 165668-12-2(Formamide,N-[(5-methyl-2-thiazolyl)methyl]-)
• 952195-05-0(ethyl(2-methyl-1,3-thiazol-5-yl)methylamine)
• 63139-99-1(methyl(2-methyl-1,3-thiazol-5-yl)methylamine)
• 1210713-28-2(Methyl[(2-methyl-1,3-thiazol-5-yl)methyl]amine dihydrochloride)
• 921145-36-0(ethyl-(5-methyl-thiazol-2-ylmethyl)-amine)
• 920481-51-2(2-Methyl-N-(5-methyl-1,3-thiazol-2-yl)methylpropan-1-amine dihydrochloride)
• 232612-47-4(2-(aminomethyl)thiazole-5-carbonitrile;hydrochloride)
• 921091-08-9((5-Methyl-1,3-thiazol-2-yl)methylamine Dihydrochloride)
• 1187928-19-3(Methyl-thiazol-2-ylmethyl-amine hydrochloride)